These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33375935)

  • 1. Parkinson's disease following COVID-19: causal link or chance occurrence?
    Li WS; Chan LL; Chao YX; Tan EK
    J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935
    [No Abstract]   [Full Text] [Related]  

  • 2. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

  • 3. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy.
    Merello M; Bhatia KP; Obeso JA
    Lancet Neurol; 2021 Feb; 20(2):94-95. PubMed ID: 33253627
    [No Abstract]   [Full Text] [Related]  

  • 5. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.
    Estrada E
    Viruses; 2021 May; 13(5):. PubMed ID: 34066091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid worsening in Parkinson's disease may hide COVID-19 infection.
    Hainque E; Grabli D
    Parkinsonism Relat Disord; 2020 Jun; 75():126-127. PubMed ID: 32414669
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 9. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the relationship between novel Coronavirus pneumonia and Parkinson's disease.
    Xi X; Han L
    Medicine (Baltimore); 2022 Nov; 101(46):e31813. PubMed ID: 36401405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
    Follmer C
    Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus Disease 2019 Case Fatality and Parkinson's Disease.
    Zhang Q; Schultz JL; Aldridge GM; Simmering JE; Narayanan NS
    Mov Disord; 2020 Nov; 35(11):1914-1915. PubMed ID: 32954522
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's disease and related syndromes.
    Weiner WJ
    Med Sect Proc; 1993; ():195-203. PubMed ID: 8078870
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-Parkinson akinetic-rigid syndromes.
    Riley DE; Lang AE
    Curr Opin Neurol; 1996 Aug; 9(4):321-6. PubMed ID: 8858193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of COVID-19 on Access to Parkinson's Disease Medication.
    Cheong JL; Goh ZHK; Marras C; Tanner CM; Kasten M; Noyce AJ;
    Mov Disord; 2020 Dec; 35(12):2129-2133. PubMed ID: 32860226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
    Outeiro TF; Krisko A
    Mov Disord; 2021 Feb; 36(2):278-279. PubMed ID: 33599004
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.
    Leta V; Rodríguez-Violante M; Abundes A; Rukavina K; Teo JT; Falup-Pecurariu C; Irincu L; Rota S; Bhidayasiri R; Storch A; Odin P; Antonini A; Ray Chaudhuri K
    Mov Disord; 2021 Jun; 36(6):1287-1289. PubMed ID: 33890344
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 19. Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.
    Soares C; Carneiro DR; Dias R; Ferreira D; Sousa M; Oliveira A; Massano J; Morgadinho A; Rosas MJ; Araújo R
    Mov Disord; 2021 Jun; 36(6):1285-1286. PubMed ID: 33834516
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinson's disease. A review.
    Voiculescu V
    Rom J Neurol Psychiatry; 1991; 29(3-4):103-10. PubMed ID: 1820097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.